Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet–visible high-performance liquid chromatography
- 10 July 2002
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 779 (2) , 259-269
- https://doi.org/10.1016/s1570-0232(02)00395-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Polyethylenglykol-umhülltes (pegyliertes) liposomales DoxorubicinDrugs, 1997
- A Sensitive and Simple High-Performance Liquid Chromatographic Method for the Determination of Doxorubicin and Its Metabolites in PlasmaTherapeutic Drug Monitoring, 1993
- A Sensitive and Simple High-Performance Liquid Chromatographic Method for the Determination of Mitoxantrone in PlasmaTherapeutic Drug Monitoring, 1993
- Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1992
- Mean Time Parameters in PharmacokineticsClinical Pharmacokinetics, 1989
- High-performance liquid chromatographic determination of doxorubicin in tissues after solid phase extractionJournal of Pharmaceutical and Biomedical Analysis, 1988
- LiposomesScientific American, 1987
- Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: Evidence from metabolites identified in serumEuropean Journal of Cancer and Clinical Oncology, 1986
- Loop-Column Extraction and Liquid Chromatographic Analysis of Doxorubicin and Three Metabolites in PlasmaTherapeutic Drug Monitoring, 1985
- Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesiusBiotechnology & Bioengineering, 1969